Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

Abstract Purpose New treatment strategies, particularly the introduction of molecular-targeted agents and appropriate patient selection based on histology and/or genotyping, have progressed markedly in recent years, and the overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patient...

Full description

Bibliographic Details

Published in:	Journal of Cancer Research and Clinical Oncology
Main Authors:	Masayuki Aboshi, Masayuki Kaneko, Mamoru Narukawa
Format:	Article
Language:	English
Published:	Springer 2014-02-01
Subjects:	Meta-analysis Overall survival Progression-free survival Post-progression survival Non-small cell lung cancer
Online Access:	https://doi.org/10.1007/s00432-014-1617-3